Product Images Duloxetine Hydrochloride

The text describes a figure, specifically "Figure 1", which shows a Kaplan-Meier estimation of the cumulative proportion of patients with relapse in Study 5. The figure includes a graph, represented by a line, indicating the percentage of patients with relapse over time from randomization to relapse (measured in days). The text also contains some unreadable characters.*

The figure shows the proportion of patients who experienced a relapse over time, measured in days since randomization to treatment with either a placebo or Duoxatine. The x-axis shows the time elapsed in days, whereas the y-axis shows the proportion of patients experiencing relapse. The figure suggests that Duoxatine may provide a benefit in reducing relapse compared to a placebo.*

The text provides information about the effectiveness of different doses of duloxetine and a placebo in reducing pain in individuals with DPNP-1. The graph in Figure 3 shows the percentage of patients who experienced different levels of pain relief. There is no additional information available.*

The text appears to be a graph showing the percentage of patients achieving various levels of pain relief as measured by 24-hour average pain severity, with three groups: Duloxeline 60 mg twice daily, Duloxefine 60 mg once daily, and a placebo group. The percentage of patients improved is listed as 8.*

This document appears to be a graph displaying the percentage of patients improved while taking Duloxetine at either 60mg or 120mg once a day, compared to a placebo. The x-axis represents the percent improvement in pain from baseline, while the y-axis measures the percentage of patients improved. At the far right of the graph, Duloxetine at 60mg and 120mg show a 100% improvement rate.*

This is a description for prescription medication. The medication is called Duloxetine and is in the form of delayed-release capsules. It is stored at a temperature between 20° to 25°C (68 to 77°F), however, it can tolerate excursions up to 15° to 30°C (59 to 86°F). The usual dosage is listed in the accompanying information. The manufacturer is Torrent Pharmaceuticals and the medication should be kept out of reach of children. The package contains 100 capsules and a medication guide should be provided to patients by the pharmacist. Please note that the information was obtained through and some words or characters may be incorrect or missing.*

This is the output of a medication label for a container of 100 capsules of duloxetine hydrochloride, each containing 33.68 mg of duloxetine. Duloxetine is a delayed-release capsule used to treat major depressive disorder, anxiety disorder, and chronic musculoskeletal pain among other conditions. The usual dosage instructions are not available in this text, and the pharmacist is instructed to dispense the medication guide along with the medication to each patient. The medication should be kept at room temperature in a tight container with a child-resistant closure.*

This is a medication description for Duloxetine Delayed-Release Capsules, USP. Each capsule contains 60mg of Duloxetine hydrochloride USP. It should be stored in a tight container with a child-resistant closure and kept out of the reach of children. The recommended temperature for storage is 20° to 25° (66° to 77°F), with excursions permitted to 15° to 30°C (50° to 86°F). The prescription comes with an accompanying medication guide to be dispensed to each patient. The usual dosage is not provided and must be obtained from accompanying prescribing information. This medication is manufactured by Torrent Pharmaceuticals LTD, India and is being produced for Torrent Pharma, Levittown, PA.*